Trevi Therapeutics Inc
Biotechnology
Healthcare
TRVI
118 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
8.60
52 week high
9.75
high
8.60
52 week low
0.00
previous Close
8.55
P/E ratio
market cap
724 M
div yield
0
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top